The Effect of Continuation of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Before Kidney Transplantation

被引：0
|
作者：
Baek, C. [1 ]
Kim, H. [1 ]
Park, S. [2 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Asan Med Ctr, Coll Med, Seoul 138736, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A223
引用
收藏
页码：S708 / S709
页数：2
相关论文
共 50 条
  • [31] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [32] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [33] Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker
    Tanemoto, M
    Abe, T
    Obara, N
    Abe, M
    Satoh, F
    Ito, S
    HYPERTENSION RESEARCH, 2003, 26 (10) : 863 - 868
  • [34] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [35] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [36] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [37] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [38] Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure
    Anand, Inder S.
    Bishu, Kalkidan
    Rector, Thomas S.
    Ishani, Areef
    Kuskowski, Michael A.
    Cohn, Jay N.
    CIRCULATION, 2009, 120 (16) : 1577 - 1584
  • [39] Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker on oxidative stress and metabolism of elements in kidney of STZ-induced diabetic rats
    Ozsobaci, Nural Pastaci
    Karatas, Metehan
    Tuncdemir, Matem
    Ozcelik, Dervis
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 751
  • [40] Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease"
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Chiang, Wen-Chih
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (01) : 95 - 96
12345